Thomas Jefferson University

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Dodick, David
One or more keywords matched the following items that are connected to Dodick, David
Item TypeName
Concept Calcitonin Gene-Related Peptide
Concept Receptors, Calcitonin Gene-Related Peptide
Academic Article Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial.
Academic Article Fremanezumab for the Preventive Treatment of Chronic Migraine.
Academic Article Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study.
Academic Article Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
Academic Article Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine.
Academic Article Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers.
Academic Article Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis.
Academic Article Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan.
Academic Article Site of effect of LY2951742 for migraine prophylaxis--authors' reply.
Academic Article Prevention of stress- or nitric oxide donor-induced medication overuse headache by a calcitonin gene-related peptide antibody in rodents.
Academic Article Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.
Academic Article Vascular safety of erenumab for migraine prevention.
Academic Article CGRP antagonists in the acute treatment of migraine.
Academic Article Ubrogepant for the Treatment of Migraine.
Academic Article Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial.
Academic Article ARISE: A Phase 3 randomized trial of erenumab for episodic migraine.
Academic Article Anatomy and immunochemical characterization of the non-arterial peptidergic diffuse dural innervation of the rat and Rhesus monkey: Implications for functional regulation and treatment in migraine.
Academic Article A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine.
Academic Article Triptan-induced latent sensitization: a possible basis for medication overuse headache.
Academic Article Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
Academic Article Antimigraine efficacy of telcagepant based on patient's historical triptan response.
Academic Article Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial.
Academic Article CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications.
Academic Article TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points.
Academic Article Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines.
Academic Article BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial.
Academic Article Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study.
Academic Article Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials.
Academic Article Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials.
Academic Article Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long-term clinical trial data.
Academic Article Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis.
Academic Article Considering Patient Sex in Prescribing CGRP Receptor Antagonists for Short-Term Treatment of Migraine.
Academic Article Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex.
Academic Article Blood pressure elevation in erenumab-treated patients with migraine: A retrospective real-world experience.
Academic Article Potential treatment targets for migraine: emerging options and future prospects.
Academic Article Pharmacotherapies for Migraine and Translating Evidence From Bench to Bedside.
Academic Article Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial.
Academic Article Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial.
Search Criteria
  • C Peptide